Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in <i>Acinetobacter baumannii</i>
Carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) is the most detrimental pathogen that causes hospital-acquired infections. Tigecycline (TIG) is currently used as a potent antibiotic for treating CRAB infections; however, its overuse substantially induces the development of res...
Main Authors: | Hyejin Cho, Tesalonika Sondak, Kwang-sun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/4/1251 |
Similar Items
-
Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01) -
The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
by: Liping Li, et al.
Published: (2020-10-01) -
Resistance mechanisms of tigecycline in Acinetobacter baumannii
by: Chunli Sun, et al.
Published: (2023-05-01) -
Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016–2018)
by: Harald Seifert, et al.
Published: (2022-12-01) -
Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
by: Jeongwoo Jo, et al.
Published: (2021-10-01)